DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism

Information source: University of Aarhus
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypogonadism

Intervention: Testosterone (Testogel), GnRH analog (Leuprorelide) and Placebo (Drug)

Phase: N/A

Status: Completed

Sponsored by: University of Aarhus

Official(s) and/or principal investigator(s):
Jens S Christensen, Professor, Principal Investigator, Affiliation: Medical Department M, Aarhus University Hospital, Denmark


Testosterone(T) has known effects on many organ systems, although many of its metabolic actions are unrevealed. T is an anabolic hormone stimulating protein synthesis but this effect has barely been investigated in controlled studies. It also has lipolytic actions influencing body composition, but little is known of its regional impact on fat tissue. T affects insulin sensitivity. There is an increased incidence of hypogonadism in type 2 diabetes, and among patients with hypogonadism there is an increased incidence of type 2 diabetes. The actions of testosterone on glucose metabolism are unknown. The purpose of this study is therefore to: Investigate the lipolytic effect of testosterone on muscle and fat tissue. To gain insight in the intracellular mechanisms of testosterone on lipolysis and investigate possible regional differences in lipolysis and changes in body composition. Finally to investigate the effect of short term experimental hypogonadism and acute testosterone substitution on cytokines, insulin sensitivity and protein metabolism. The trial is a randomised double blinded cross-over study of 4 x 2 days with an interval of 1 month in between. 12 healthy young men will receive GnRH treatment over a 3 month period and examined on 4 occasions with various degrees of T substitution and placebo . The examinations take place at the Research Lab within the Medical Department M. The investigations are deemed relevant to the understanding of the interrelationship between male hypogonadism and type 2 diabetes. The hypothesis is that T has beneficial effects on carbohydrate, fat and protein metabolism. The generated knowledge would therefore hopefully improve prophylaxis, screening and early treatment of both group of patients.

Clinical Details

Official title: Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism

Study design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science

Primary outcome: Testosterone influence on Insulin Sensitivity, Lipolysis and protein metabolism

Secondary outcome: Testosterone influence on Body composition by DEXA scan, Energy expenditure by indirect Calorimetry and VO2 max test


Minimum age: 20 Years. Maximum age: 35 Years. Gender(s): Male.


Inclusion Criteria:

- Male, age 20-35

- Normal biochemical screen and ECG

Exclusion Criteria:

- Heart disease

- BMI>25

- Diabetes

- Antecedent or present cancer

- Vascular disease

- Antecedent or present hormone treatment

- Medical treatment with known effects on fat metabolism

- Big X-ray examinations equivalent to, or more than a chest x-ray and all kinds of CT

scans until 6 month before the start of the study and during the study.

Locations and Contacts

Medical department M and Investigational Laboratories, Aarhus C, Jutland 8000, Denmark
Additional Information

Related publications:

Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004 Jul;89(7):3313-8.

Starting date: September 2007
Last updated: October 21, 2009

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017